← Leaderboards
Jeffrey D Winkler
University Of Pennsylvania
$6,111,195
Attributed
$8,225,662
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $731.7K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,225,662 · 5
By mechanism
R01$5,953,241 · 4
P01$2,272,421 · 1
Top collaborators
- Ronen Marmorstein6 shared
- Nadia Dahmane2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ronen Marmorstein$40,497,435
- Ivan Julian Dmochowski$11,950,518
- Clifford S. Deutschman$5,683,019
- Eric Meggers$3,788,212
- Mark A Sellmyer$4,461,409
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignIn VitroStructureScaffoldMalignant NeoplasmsLeadCellsPlayBaseTumorCancer TherapyMelanomaInhibitor/AntagonistPharmaceutical PreparationsSignal TransductionBraf GeneKinase InhibitorCombined Modality TherapyTargeted TreatmentMediatingGrowthSignal PathwayBiological ModelsNovel Therapeutic Intervention
Grant awards (20)
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma$642,782
R01 · FY2023 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma$631,536
R01 · FY2022 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma$643,599
R01 · FY2021 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma$731,727
R01 · FY2020 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma$667,564
R01 · FY2019 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma$58,647
R01 · FY2019 · CA
Novel Potent Autophagy Inhibitors for Melanoma$455,888
P01 · FY2017 · CA · contact PI
Novel Potent Autophagy Inhibitors for Melanoma$455,948
P01 · FY2016 · CA · contact PI
Novel Potent Autophagy Inhibitors for Melanoma$456,253
P01 · FY2015 · CA · contact PI
Novel Potent Autophagy Inhibitors for Melanoma$439,280
P01 · FY2014 · CA · contact PI
Novel Potent Autophagy Inhibitors for Melanoma$465,052
P01 · FY2013 · CA · contact PI
Inhibitors of Hedgehog Signaling For Brain Cancer Chemotherapy$421,118
R01 · FY2010 · CA · contact PI
Inhibitors of Hedgehog Signaling For Brain Cancer Chemotherapy$431,961
R01 · FY2009 · CA · contact PI
Vinylogous Amide Photochemistry in Organic Synthesis$209,877
R01 · FY2005 · GM
Vinylogous Amide Photochemistry in Organic Synthesis$211,580
R01 · FY2004 · GM
Synthesis of Bioactive Substances$260,682
R01 · FY2003 · CA
Vinylogous Amide Photochemistry in Organic Synthesis$235,518
R01 · FY2003 · GM
Synthesis of Bioactive Substances$260,682
R01 · FY2002 · CA
Synthesis of Bioactive Substances$276,552
R01 · FY2001 · CA
STRATEGIES FOR THE SYNTHESIS OF ANTITUMOR COMPOUNDS$269,416
R01 · FY2000 · CA